Point72 Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Buy |
202,815
+97,730
| +93% | +$865K | ﹤0.01% | 866 |
|
|
2025
Q1 | $823K | Buy |
+105,085
| New | +$823K | ﹤0.01% | 908 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1282 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1233 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1207 |
|
|
2024
Q1 | – | Sell |
-285,816
| Closed | -$4.04M | – | 1435 |
|
|
2023
Q4 | $4.04M | Buy |
+285,816
| New | +$4.04M | 0.01% | 772 |
|
|
2023
Q3 | – | Sell |
-676,260
| Closed | -$11.1M | – | 1776 |
|
|
2023
Q2 | $11.1M | Buy |
676,260
+220,260
| +48% | +$3.63M | 0.03% | 491 |
|
|
2023
Q1 | $4.18M | Buy |
456,000
+179,034
| +65% | +$1.64M | 0.01% | 697 |
|
|
2022
Q4 | $1.98M | Buy |
+276,966
| New | +$1.98M | 0.01% | 760 |
|
|
2016
Q3 | – | Sell |
-461,839
| Closed | -$4.96M | – | 651 |
|
|
2016
Q2 | $4.96M | Buy |
461,839
+102,881
| +29% | +$1.1M | 0.03% | 394 |
|
|
2016
Q1 | $3.96M | Buy |
358,958
+291,946
| +436% | +$3.22M | 0.03% | 420 |
|
|
2015
Q4 | $818K | Buy |
+67,012
| New | +$818K | 0.01% | 575 |
|
|
2015
Q2 | – | Sell |
-355,800
| Closed | -$6.4M | – | 664 |
|
|
2015
Q1 | $6.4M | Buy |
+355,800
| New | +$6.4M | 0.04% | 370 |
|